Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL869451 | 0.87 | — | — | |
| SCHEMBL4660459 | 0.81 | — | — | |
| SCHEMBL1396809 | 0.81 | IDO1 (0.30) | IDO1TDO2 | |
| SCHEMBL9658110 | 0.80 | TSHR (0.32) | — | |
| SCHEMBL9356975 | 0.80 | — | — | |
| SCHEMBL4660494 | 0.79 | — | — | |
| SCHEMBL9659478 | 0.79 | — | — | |
| SCHEMBL9353048 | 0.78 | IDO1 (0.32) | IDO1TDO2 | |
| SCHEMBL1396769 | 0.78 | CYP1A2 (0.34) | — | |
| SCHEMBL22578964 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200701-B1 | DIMETHYLCYCLOHEXYL DERIVATIVES AS MALODOR NEUTRALIZERS | GIVAUDAN SA (CH) | 2011-03-02 | — | — | EP | claimed |
| US-20100209378-A1 | Dimethylcyclohexyl Derivatives as Malodor Neutralizers | GIVAUDAN SA (CH) | 2010-08-19 | — | — | US | claimed |
| EP-2200701-A1 | DIMETHYLCYCLOHEXYL DERIVATIVES AS MALODOR NEUTRALIZERS | Givaudan SA (CH) | 2010-06-30 | — | — | EP | claimed |
| WO-2009030059-A1 | DIMETHYLCYCLOHEXYL DERIVATIVES AS MALODOR NEUTRALIZERS | GIVAUDAN SA (CH) | 2009-03-12 | — | — | WO | claimed |
| EP-2200701-B1 | DIMETHYLCYCLOHEXYL DERIVATIVES AS MALODOR NEUTRALIZERS | GIVAUDAN SA (CH) | 2011-03-02 | — | — | EP | disclosed |
| US-20100209378-A1 | Dimethylcyclohexyl Derivatives as Malodor Neutralizers | GIVAUDAN SA (CH) | 2010-08-19 | — | — | US | disclosed |
| EP-2200701-A1 | DIMETHYLCYCLOHEXYL DERIVATIVES AS MALODOR NEUTRALIZERS | Givaudan SA (CH) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009030059-A1 | DIMETHYLCYCLOHEXYL DERIVATIVES AS MALODOR NEUTRALIZERS | GIVAUDAN SA (CH) | 2009-03-12 | — | — | WO | disclosed |
| EP-0472966-B1 | Esters and their use in perfumery | FIRMENICH & CIE (CH) | 1994-09-28 | — | — | EP | disclosed |
| US-5166412-A | ESTERS AND THEIR USE IN PERFUMERY | FIRMENICH S.A. (CH) | 1992-11-24 | — | — | US | disclosed |
| EP-0472966-A1 | Esters and their use in perfumery | FIRMENICH SA (CH) | 1992-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100209378-A1 | Dimethylcyclohexyl Derivatives as Malodor Neutralizers | ME1, MAL2, LPO | IDO1 1811/4885TDO2 590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.